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Abstract: Morphine is an opioid drug. Long-term use can cause morphine dependence or addiction, and there are cogni-
tive dysfunction such as abnormal mental behavior, decline in learning and memory, and decline in executive ability. 
The occurrence of this disease is related to many factors, such as oxidative stress, hippocampal neuronal injury, mito-
chondrial function injury, etc. Tau protein is a microtubule-associated protein involved in nervous system development. 
Studies have found that hyperphosphorylation of tau proteins can cause apoptosis of hippocampal neurons
[1]
, and tau 
proteins can cause oxidative stress
[2]
. Therefore, tau proteins play an important role in the pathogenesis of cognitive 
disorders. The relationship between morphine dependence and cognitive dysfunction is now reviewed. 
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Morphine has a strong analgesic effect and is often 
used in anaesthesia and severe pain caused by terminal 
tumors. Long-term use of morphine can produce a strong 
dependence, leading to cognitive dysfunction, mental 
disorders, behavioral disorders and so on, and eventually 
cause psychological and physical damage to patients, and 
can lead to family rupture, which poses a threat to social 
stability. Cognitive impairment in patients with cognitive 
dysfunction caused by morphine dependence is mainly 
manifested in cognitive flexibility and working memory; 
cognitive flexibility is mainly reflected in selective atten-
tion, executive function, and working memory load abil-
ity. Reduced working memory load can cause a decline 
in decision-making ability
[3–4]
. The mechanism of cogni-
tive dysfunction caused by morphine dependence is gen-
erally considered to be associated with mechanisms such 
as oxidative stress, hippocampal neuronal damage
[3–4]
, 
apoptosis, abnormal secretion of monoamine neuro-
transmitters, altered synaptic plasticity, and mitochondri-
al dysfunction. However, the specific pathogenesis re-
mains unclear. Tau protein is a tubulin involved in the 
regulation of tubulin stability
[3]
. 
Accumulation of neuronal fiber tangles caused by 
hyperphosphorylation of tau proteins is closely related to 
the characteristic manifestations of cognitive dysfunction 
in Alzheimer’s disease. Morphine is an opioid, long-term 
use can cause morphine dependence or addiction, and 
there are mental and behavioral disorders, learning and 
memory decline, executive ability decline and other cog-
nitive dysfunction
[4]
. Recent studies have confirmed that 
acute and chronic morphine treatment can cause abnor-
mal hyperphosphorylation of tau proteins and nerve mi-
crofilaments in the cerebral cortex
[5–6]
. As a result tau 
proteins may be associated with cognitive impairment 
following morphine dependence. This article reviews the  
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overview of tau proteins and their phosphorylation regu-
lation, tau proteins and other cognitive disorders related 
diseases, tau proteins and morphine dependence, tau 
proteins may be involved in regulating the pathogenesis 
of cognitive dysfunction caused by morphine depend-
ence, in order to provide new ideas for the treatment and 
prevention of cognitive dysfunction caused by morphine 
dependence. 
1. Overview and phosphorylation 
regulation of tau proteins 
1.1 Overview of tau proteins 
Tau protein is a microtubule related protein, which 
can be involved in regulating the stability of tubulin. 
Human tau genes on chromosome 17(17 q21-q22). And 
there are six tau isomers in the brain, is caused by or 
without exon 2, 3/10 messenger mRNA composed of 
alternative splicing. Exon 10 contains a 
bule binding region, exon 10 insertion provides four re-
peat (4 R) tau isomers, and 3 repeat (3 R) tau isomers do 
not require the involvement of exon 10
[5]
. The adult brain 
mainly expresses 3 R and 4 R tau, under physiological 
conditions, they are mainly distributed in axons of neu-
rons
[6]
. Neuronal fiber tangles composed of hyperphos-
phorylation of tau proteins are closely related to the main 
pathogenic causes of Alzheimer’s disease
[7]
. Diseases 
occur around the terminal binding sites of tubulin C, 
which leads to the decrease of microtubule binding abil-
ity and the weakening of microtubule binding ability, 
indicating that microtubule regulation is impaired
[8–9]
. 
Tau with localized misdistribution can also lead to im-
paired microtubule regulatory function. Mislocalized tau 
can be hyperphosphorylated while forming fibrous seeds 
and deposits. Furthermore, the stability of hyperphos-
phorylated proteins and normal tau proteins increased. 
Abnormal action of filamentous actin with stable tau 
proteins can lead to prominent damage, mitochondrial 
integrity defects, and actin instability. As a result, patho-
logical changes in tau proteins can damage cytoskeleton 
system, cell transport system, mitochondrial integrity and 
signal transduction system. As a result, tau proteins ac-
cumulate in a group of brain cells and transfer to other 
regions can lead to disease and neurodegeneration. 
1.2 Phosphorylation regulation of tau pro-
teins 
Tau protein is a phosphoprotein whose phosphory-
lation state determines its function. The binding of 
phosphate group depends not only on the conformation 
of tau protein, but also on the balance between tau pro-
tein kinase and protein phosphatase activity. Normal tau 
proteins usually bind 2-3 phosphatases, and when the 
protein kinase and protein phosphatase are out of balance, 
tau protein-bound phosphatases become 5-9. Current 
research finds
[8]
, there are 21 tau protein phosphorylation 
sites in Alzheimer’s disease (AD) patients, protein kinase 
(PDPK) and non-proline guided protein kinase 
(non-PDPK) phosphorylation can be guided by proline. 
PDPK phosphorylation of serine and threonine contain-
ing Ser/Thr-pro sequences, including cell cycle depend-
ent protein-5(CDK-5), glycogen synthesis ki-
nase-3(GSK-3), mitogen-activated protein kinase 
(MAPK), the non-PDPK is mainly about Ser/Thr-X con-
tained the serine of the sequence is phosphorylated with 
threonine, including calmodulin dependent protein ki-
nase II (CaMKⅡ), microtubule binding regulatory ki-
nase (MARK) and cAMP dependent protein kinase 
(PKA), etc. Moreover
[9]
, protein phosphatase plays an 
important role PP2A regulating tau protein phosphoryla-
tion. The phosphorylation of Thr1620/1623 and Ser136 
at the two sites of MAP-2 is mainly regulated by CaMK
Ⅱ and GSK-3β, and PP2A plays an important role in 
dephosphorylation. Studies
[10]
 have confirmed that the 
up-regulation of tau and MAP-2 phosphorylation levels 
in acute morphine mainly by inhibiting PP2A activity, 
while the activation of tau and MAP-2 phosphorylation 
in chronic morphine by enhancing GSK-3β and PKA 
activity sex. Patrick found that P25/CDK5 complexes 
can not only induce hyperphosphorylation of tau pro-
teins, but also reduce the ability of tau proteins to bind to 
microtubules. Wang Xinbo
[11]
 and others confirmed that 
Anshen Dingzhi can inhibit tau protein phosphoryla-
tion by activating BDNF/TrKB signal transduction 
pathway, thus improving the learning and memory ability 
of AD rats. 
2. Tau proteins and other cognitive 
disorders 
The biological activity of tau protein is the basis of 
maintaining its function. Moderate phosphorylation can 
maintain the biological activity of tau protein, but hy-
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perphosphorylation can cause tau protein to accumulate 
and form neuronal fiber tangles (NFT), thus losing 
its biological activity. The study found that tau protein 
phosphorylation changes in Alzheimer’s disease, Par-
kinson’s disease, stroke with vascular cognitive dysfunc-
tion, post-operative cognitive impairment and other cog-
nitive impairment-related diseases, while tau protein 
phosphorylation can cause a decline in microtubule as-
sembly ability. It can also further damage microtubules 
through tubulin-related protein MAP1 and MAP2, af-
fecting the synthesis, transport, release of neurotransmit-
ters resulting in abnormal intercellular signal transduc-
tion. Hence, hyperphosphorylation of tau proteins is 
thought to be involved in regulating the pathogenesis of 
multiple cognitive impairment-related diseases. 
2.1 Tau proteins and Alzheimer’s disease 
The characteristic lesion of Alzheimer’s disease 
(AD)
[12]
 neurofibrillary tangles (NFTs) is an important 
cause of neuronal lesions, which can be used as a marker 
of brain aging and is positively related to the degree of 
cognitive impairment in AD. Tau protein can produce a 
large number of abnormal post-translational modifica-
tions and aggregate to form paired helical filaments, 
NFTs is formed by further deposition of paired helical 
filaments. Phosphorylation and interception are the main 
forms of post-translational modification of tau proteins, 
and are closely related to the occurrence and develop-
ment of AD. The degree of tau protein phosphorylation 
in the brain of AD patients is 3-4 times higher than that 
of ordinary people
[13]
. Tau protein phosphorylation is 
mainly regulated by phosphatase and phosphokinase to 
maintain the equilibrium state. When the equilibrium 
state is broken, it can cause abnormal hyperphosphoryla-
tion of tau protein, and hyperphosphorylation improves 
the aggregation ability of tau protein significantly. Loss 
of original function, accumulation in the form of spiral 
filaments NFTs, resulting in neuronal degeneration 
damage. 
2.2 Tau protein and Parkinson’s disease 
Parkinson’s disease (PD) is a common dyskinesia 
disease, the main pathological features of which are pro-
gressive neuronal degeneration in striatum and corpus 
callosum, and the widespread existence α- synaptic nu-
cleoprotein aggregates-Louis corpuscles in cytoplasm. 
Where cognitive dysfunction is PD common nonmotor 
symptom, including Parkinson’s disease dementia (PDD) 
and Parkinson’s disease mild cognitive impairment 
(PD-MCI). The results showed
[14]
 that the genotypes 
H1/H2 microtubule related tau protein (MAPT) genes 
and apolipoprotein Eɛ alleles were correlated with the 
dementia rate of Parkinson’s disease. Cerebrospinal fluid 
β- amyloid42 decreased, phosphorylated tau protein and 
total tau protein levels
[15]
 increased in PDD patients. 
Moreover, it was found that the tau level of serum phos-
phorylation in PD patients was significantly higher than 
that in the control group, and the level of serum phos-
phorylation tau in PD-MCI group was significantly low-
er than that in PDD group. The higher the serum tau pro-
tein phosphorylation level, the worse the prognosis. 
2.3 Tau proteins and post-stroke cognitive 
impairment 
Cognitive dysfunction after stroke belongs to vas-
cular cognitive dysfunction (VCI), which refers to the 
impairment of one or more cognitive fields such as exec-
utive ability, language comprehension calculation, brain 
memory, structural ability and expression application. 
The study suggests that
[16]
 β- abnormal proteins produced 
during stroke such as amyloid 1-42(Aβ-42) and tau pro-
tein may be associated with vascular cognitive dysfunc-
tion after stroke. Other studies have suggested that
[17]
 tau 
proteins are related to the formation of microtubules in 
neuronal cells and are specific proteins in the nervous 
system. After stroke, tau are released from nerve cells 
into cerebrospinal fluid and leak to peripheral blood 
through damaged blood-brain barrier. Its level may be 
related to the degree of brain injury. The results showed 
that
[18]
 the Aβ-42 of tau protein in the experimental group 
was lower than that in the control group, and the differ-
ence was statistically significant. The tau protein level 
was negatively correlated with the MoCA and MMSE 
score, suggesting that the Aβ-42 and tau protein level 
was associated with vascular cognitive impairment after 
stroke. 
3. Tau protein and morphine de-
pendence 
Morphine is an opioid that can lead to cognitive de-
cline such as learning and memory, but the specific rea-
sons are unknown. Both acute and chronic morphine 
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treatment can increase the phosphorylation of tau protein 
and nerve microfilament in rat cerebral cortex. Recent 
studies have confirmed that acute morphine treatment 
can increase the expression of cycle-dependent protein 
kinase-5 (CDK5) in cerebral cortex cells, and CDK5 is 
one of the important kinases that catalyze the phosphor-
ylation of tau protein and neurofilament protein. In-
creased CDK5 activity can cause abnormal hyperphos-
phorylation of tau protein and neurofilament protein. But 
other studies have different views. Narita
[19]
 contet and 
other studies found that there was no significant change 
in the expression level of cerebral cortex CDK5 chronic 
morphine treatment, but the expression level of p-CDK5 
(Ser159) increased and the activity of CDK5 increased. 
Suggesting that abnormal hyperphosphorylation of tau 
proteins and neurofilament proteins may be associated 
with increased p-CDK5 (ser159) expression levels and 
upregulation of CDK5 activity. Studies have also con-
firmed that
[20]
 high dose exogenous CCK-8 can signifi-
cantly reduce the damage of spatial reference memory in 
morphine dependent mice, and CCK-8 intervention can 
increase the PKA and GSK-3β activity caused by in-
creasing the PP2A activity caused by acute morphine 
action and decreasing the chronic morphine action. It 
inhibited the increase of tau and MAP-2 phosphorylation 
induced by morphine. 
4. Mechanisms of possible involve-
ment of tau proteins in mor-
phine-dependent cognitive impair-
ment 
Tau protein affects cognitive dysfunction caused by 
morphine dependence. A number of studies have found 
that tau proteins can not only affect apoptosis, but also 
affect nervous system and cognitive function through 
other ways. At present, the research includes the follow-
ing aspects. 
4.1 Tau proteins affect apoptosis 
Apoptosis is an important regulatory mechanism to 
maintain the relative stability of physiological state. Its 
abnormal increase or decrease may lead to the change of 
function or structure of tissues and organs. The effects
[21]
 
of stilbene glycoside (TSG) on the phosphorylation of 
tau protein in NG108-15 cells induced by okadaic acid 
(OA) were studied. It was found that OA could lead to 
abnormal phosphorylation of tau protein in nerve cells 
and increase the aggregation of tau protein. Finally, 
apoptosis was caused. Acrylamide (AA)
[22]
 induced 
apoptosis in vivo and in vitro, accompanied by oxidative 
stress. Oxidative stress can induce autophagy in neurons 
in the brain. But if the ROS level in the cell exceeds the 
clearance range of autophagy, it will cause excessive 
autophagy and eventually lead to autophagic death. The 
study found that
[23]
 H2O2 acting on hippocampal neurons 
HT22 cells, autophagy bodies gradually increased and 
eventually died with the long action of free radicals, 
suggesting that oxidative stress can induce hippocampal 
neuronal death. The hippocampus is a related brain re-
gion of learning, memory and emotion in the brain. 
Studies have confirmed that local changes in the hippo-
campus, such as volume reduction, neuronal apoptosis or 
death, are important causes of cognitive function chang-
es. 
4.2 Tau proteins affect mitochondrial dys-
function 
As a “power plant” in vivo, mitochondria play an 
important role in the formation of ATP through the pro-
cess of oxidative phosphorylation. The damaged mito-
chondria can stimulate the production of a large number 
of reactive oxygen free radicals, which can cause oxida-
tive damage to the central nervous system. The results 
showed that the expression of human tau protein could 
cause the dynamic imbalance of mitochondrial division 
and fusion between HEK293 cells and primary neurons, 
and the neuronal process was significantly shortened and 
the cell viability decreased
[24]
. Damage to mitochondrial 
function can affect mitochondrial endoplasmic reticulum 
(MAMs) structural coupling. Mitochondrial-endoplasmic 
reticulum structural coupling (MAMs) is a physical 
and biochemical connection between mitochondria and 
endoplasmic reticulum, and it is also a bridge between 
their structure and function. Studies have confirmed that 
changes in MAMs structure and function may be a key 
link in the pathogenesis of Parkinson’s disease, Alz-
heimer’s disease and other types of cognitive disorders, 
so MAMs injury is associated with cognitive dysfunc-
tion. 
4.3 Tau proteins affect endoplasmic reticu-
lum-related degradation pathways 
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The endoplasmic reticulum related degradation 
(ERAD) pathway refers to the process of degradation by 
the ubiquitin proteasome system (UPS) when the newly 
synthesized proteins or polypeptide molecules of the 
endoplasmic reticulum are non-folded proteins or mis-
folded proteins increase or cannot return to normal con-
formation. Abnormal tau protein accumulation can de-
stroy endoplasmic reticulum related degradation path-
way
[25]
, hinder ubiquitin dependent proteasome degrada-
tion pathway, and then cause folding protein response. At 
the same time, endoplasmic reticulum stress is activated 
to induce neuronal apoptosis, which further affects cog-
nitive function. 
4.4 Effects of tau proteins on oxidative stress 
Oxidative stress is a physiological process trig-
gered by the breaking of the balance between reactive 
oxygen species and antioxidants, which can lead to lipid 
peroxidation, oxidative damage to proteins and DNA, 
and ultimately neuronal damage. Studies have shown 
that abnormal phosphorylation of tau proteins occurs AD 
the brain of patients and accumulates to form spiral fila-
ments, that is, neuronal fiber tangles. However, hyper-
phosphorylated tau proteins lose the ability to bind to 
neuronal microtubules, resulting in the inability to regu-
late the structure and function of microtubules, thus 
causing neuronal axons to degenerate. The formation and 
growth of axons is the primary morphological change in 
neuronal differentiation, which makes cognitive func-
tions such as information transmission, learning and 
memory more dependent on information transmis-
sion between neurons. 
5. Summary 
To sum up, tau protein is a microtubule-related pro-
tein of nerve cells, which has the function of synthesiz-
ing and stabilizing neurons and plays an important role 
in maintaining cell morphology, cell movement, signal 
transmission and other physiological processes. The NFT 
of hyperphosphorylation and aggregation of tau protein 
is one of the main pathological features in the brain of 
AD patients. Tau protein hyperphosphorylation is con-
sidered to be AD key pathogenic factor. The study found 
that the phosphorylation level of tau protein was in-
creased in postoperative cognitive impairment, stroke 
with vascular cognitive impairment, diabetic encephalo-
pathy and other cognitive dysfunction diseases, so a large 
number of studies believe that tau protein is involved in 
the regulation of cognitive impairment mechanism. The 
study found that the level of tau protein phosphorylation 
also increased during morphine dependence, so consider 
whether tau protein phosphorylation is involved in cog-
nitive dysfunction caused by morphine dependence. This 
article reviews the overview of tau protein and its phos-
phorylation, its relationship with other cognitive disor-
ders, tau protein and morphine dependence, and its pos-
sible effects on cognitive dysfunction caused by mor-
phine dependence. In order to provide a new way of di-
agnosis and treatment for patients with cognitive dys-
function caused by morphine dependence and provide a 
new direction for the preparation of targeted drugs. 
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